Trademark: 90226712
Word
ADVANCE THE CELL & GENE THERAPY COLLECTIVE
Status
Dead
Status Code
606
Status Date
Monday, August 1, 2022
Serial Number
90226712
Mark Type
4000
Filing Date
Wednesday, September 30, 2020
Published for Opposition
Tuesday, May 4, 2021
Abandoned Date
Monday, August 1, 2022

Trademark Owner History
Precision Medicine Group, LLC - Owner At Publication

Classifications
41 Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
35 Business management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition
42 Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition
ADVANCE THE CELL AND GENE THERAPY COLLECTIVE

Trademark Events
Aug 1, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 1, 2022
Abandonment - No Use Statement Filed
Oct 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2021
Sou Extension 1 Granted
Oct 27, 2021
Sou Extension 1 Filed
Oct 27, 2021
Teas Extension Received
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 29, 2021
Approved For Pub - Principal Register
Mar 26, 2021
Teas/Email Correspondence Entered
Mar 25, 2021
Correspondence Received In Law Office
Mar 25, 2021
Teas Response To Office Action Received
Feb 24, 2021
Notification Of Non-Final Action E-Mailed
Feb 24, 2021
Non-Final Action E-Mailed
Feb 24, 2021
Non-Final Action Written
Feb 24, 2021
Assigned To Examiner
Nov 15, 2020
New Application Office Supplied Data Entered
Oct 3, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24